285 related articles for article (PubMed ID: 33174028)
1. S100A8 and S100A9 promote endothelial cell activation through the RAGE‑mediated mammalian target of rapamycin complex 2 pathway.
Zhong X; Xie F; Chen L; Liu Z; Wang Q
Mol Med Rep; 2020 Dec; 22(6):5293-5303. PubMed ID: 33174028
[TBL] [Abstract][Full Text] [Related]
2. Functional characterization of S100A8 and S100A9 in altering monolayer permeability of human umbilical endothelial cells.
Wang L; Luo H; Chen X; Jiang Y; Huang Q
PLoS One; 2014; 9(3):e90472. PubMed ID: 24595267
[TBL] [Abstract][Full Text] [Related]
3. Advanced glycation end products increase expression of S100A8 and A9 via RAGE-MAPK in rat dental pulp cells.
Nakajima Y; Inagaki Y; Kido J; Nagata T
Oral Dis; 2015 Apr; 21(3):328-34. PubMed ID: 25098709
[TBL] [Abstract][Full Text] [Related]
4. TLR4 and RAGE conversely mediate pro-inflammatory S100A8/9-mediated inhibition of proliferation-linked signaling in myeloproliferative neoplasms.
Kovačić M; Mitrović-Ajtić O; Beleslin-Čokić B; Djikić D; Subotički T; Diklić M; Leković D; Gotić M; Mossuz P; Čokić VP
Cell Oncol (Dordr); 2018 Oct; 41(5):541-553. PubMed ID: 29946821
[TBL] [Abstract][Full Text] [Related]
5. Investigating the extremes of the continuum of paracrine functions in CD34-/CD31+ CACs across diverse populations.
Landers-Ramos RQ; Sapp RM; VandeWater E; Macko J; Robinson S; Wang Y; Chin ER; Spangenburg EE; Prior SJ; Hagberg JM
Am J Physiol Heart Circ Physiol; 2017 Jan; 312(1):H162-H172. PubMed ID: 27793853
[TBL] [Abstract][Full Text] [Related]
6. Influences of S100A8 and S100A9 on Proliferation of Nasopharyngeal Carcinoma Cells through PI3K/Akt Signaling Pathway.
Wen L; Ding Y; Chen X; Tian K; Li D; Liang K; Yue B
Biomed Res Int; 2021; 2021():9917365. PubMed ID: 34604387
[TBL] [Abstract][Full Text] [Related]
7. RAGE-dependent regulation of calcium-binding proteins S100A8 and S100A9 in human THP-1.
Eggers K; Sikora K; Lorenz M; Taubert T; Moobed M; Baumann G; Stangl K; Stangl V
Exp Clin Endocrinol Diabetes; 2011 Jun; 119(6):353-7. PubMed ID: 21472666
[TBL] [Abstract][Full Text] [Related]
8. Deficiency of S100A8/A9 attenuates pulmonary microvascular leakage in septic mice.
Yu J; Zhao B; Pi Q; Zhou G; Cheng Z; Qu C; Wang X; Kong L; Luo S; Du D; Guo Y
Respir Res; 2023 Nov; 24(1):288. PubMed ID: 37978525
[TBL] [Abstract][Full Text] [Related]
9. S100A8 and S100A9 activate MAP kinase and NF-kappaB signaling pathways and trigger translocation of RAGE in human prostate cancer cells.
Hermani A; De Servi B; Medunjanin S; Tessier PA; Mayer D
Exp Cell Res; 2006 Jan; 312(2):184-97. PubMed ID: 16297907
[TBL] [Abstract][Full Text] [Related]
10. S100A8/A9 activate key genes and pathways in colon tumor progression.
Ichikawa M; Williams R; Wang L; Vogl T; Srikrishna G
Mol Cancer Res; 2011 Feb; 9(2):133-48. PubMed ID: 21228116
[TBL] [Abstract][Full Text] [Related]
11. CD68 on rat macrophages binds tightly to S100A8 and S100A9 and helps to regulate the cells' immune functions.
Okada K; Arai S; Itoh H; Adachi S; Hayashida M; Nakase H; Ikemoto M
J Leukoc Biol; 2016 Nov; 100(5):1093-1104. PubMed ID: 27312849
[TBL] [Abstract][Full Text] [Related]
12. MCAM, as a novel receptor for S100A8/A9, mediates progression of malignant melanoma through prominent activation of NF-κB and ROS formation upon ligand binding.
Ruma IM; Putranto EW; Kondo E; Murata H; Watanabe M; Huang P; Kinoshita R; Futami J; Inoue Y; Yamauchi A; Sumardika IW; Youyi C; Yamamoto K; Nasu Y; Nishibori M; Hibino T; Sakaguchi M
Clin Exp Metastasis; 2016 Aug; 33(6):609-27. PubMed ID: 27151304
[TBL] [Abstract][Full Text] [Related]
13. Proinflammatory effects of S100A8/A9 via TLR4 and RAGE signaling pathways in BV-2 microglial cells.
Ma L; Sun P; Zhang JC; Zhang Q; Yao SL
Int J Mol Med; 2017 Jul; 40(1):31-38. PubMed ID: 28498464
[TBL] [Abstract][Full Text] [Related]
14. Low concentration of S100A8/9 promotes angiogenesis-related activity of vascular endothelial cells: bridges among inflammation, angiogenesis, and tumorigenesis?
Li C; Li S; Jia C; Yang L; Song Z; Wang Y
Mediators Inflamm; 2012; 2012():248574. PubMed ID: 22685372
[TBL] [Abstract][Full Text] [Related]
15. S100A8 is a novel therapeutic target for anaplastic thyroid carcinoma.
Reeb AN; Li W; Sewell W; Marlow LA; Tun HW; Smallridge RC; Copland JA; Spradling K; Chernock R; Lin RY
J Clin Endocrinol Metab; 2015 Feb; 100(2):E232-42. PubMed ID: 25423568
[TBL] [Abstract][Full Text] [Related]
16. The expression of S100A8/S100A9 is inducible and regulated by the Hippo/YAP pathway in squamous cell carcinomas.
Li Y; Kong F; Jin C; Hu E; Shao Q; Liu J; He D; Xiao X
BMC Cancer; 2019 Jun; 19(1):597. PubMed ID: 31208368
[TBL] [Abstract][Full Text] [Related]
17. Increased proinflammatory endothelial response to S100A8/A9 after preactivation through advanced glycation end products.
Ehlermann P; Eggers K; Bierhaus A; Most P; Weichenhan D; Greten J; Nawroth PP; Katus HA; Remppis A
Cardiovasc Diabetol; 2006 Mar; 5():6. PubMed ID: 16573830
[TBL] [Abstract][Full Text] [Related]
18. Roles of calcium-binding proteins, S100A8 and S100A9, in invasive phenotype of human gastric cancer cells.
Yong HY; Moon A
Arch Pharm Res; 2007 Jan; 30(1):75-81. PubMed ID: 17328245
[TBL] [Abstract][Full Text] [Related]
19. S100a8/a9 released by CD11b+Gr1+ neutrophils activates cardiac fibroblasts to initiate angiotensin II-Induced cardiac inflammation and injury.
Wu Y; Li Y; Zhang C; A X; Wang Y; Cui W; Li H; Du J
Hypertension; 2014 Jun; 63(6):1241-50. PubMed ID: 24711518
[TBL] [Abstract][Full Text] [Related]
20. Computational Deciphering of the Role of S100A8 and S100A9 Proteins and Their Changes in the Structure Assembly Influences Their Interaction with TLR4, RAGE, and CD36.
Paramasivam S; Perumal SS; Ekambaram SP
Protein J; 2024 Apr; 43(2):243-258. PubMed ID: 38431537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
